Structures by: Khan I. U.
Total: 250
K071
C19H23NO5
Organic & biomolecular chemistry (2016) 14, 40 9476-9480
a=12.0073(4)Å b=5.9225(2)Å c=13.6415(4)Å
α=90° β=109.5840(10)° γ=90°
1-Ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C10H11NO3S
Acta Crystallographica Section E (2008) 64, 3 o558
a=7.0272(3)Å b=8.0448(4)Å c=9.5880(4)Å
α=99.124(3)° β=95.075(3)° γ=104.092(3)°
4-Chloro-2-[(E)-({4-[N-(3,4-dimethylisoxazol-5- yl)sulfamoyl]phenyl}iminio)methyl]phenolate
C18H16ClN3O4S
Acta Crystallographica Section E (2008) 64, 3 o635
a=15.1871(6)Å b=7.2555(3)Å c=16.6267(7)Å
α=90.00° β=94.081(2)° γ=90.00°
4-Bromo-2-((<i>E</i>)-{4-[(3,4-dimethylisoxazol-5- yl)sulfamoyl]phenyl}iminiomethyl)phenolate
C18H16BrN3O4S
Acta Crystallographica Section E (2008) 64, 4 o720
a=15.3846(10)Å b=7.2235(5)Å c=16.5520(11)Å
α=90.00° β=93.201(4)° γ=90.00°
(<i>E</i>)-2-(2-Fluorobenzylidene)butanoic acid
C11H11F1O2
Acta Crystallographica Section E (2008) 64, 4 o733
a=4.1895(4)Å b=17.4362(19)Å c=13.8134(15)Å
α=90.00° β=96.719(3)° γ=90.00°
4-(5-Chloro-2-hydroxybenzylideneamino)-N-(4,6-dimethylpyrimidin-2- yl)benzenesulfonamide
C19H17ClN4O3S
Acta Crystallographica Section E (2008) 64, 4 o648
a=11.7332(7)Å b=13.8506(6)Å c=23.6635(14)Å
α=90.00° β=90.00° γ=90.00°
4-{2-[(5-Chloro-2-hydroxybenzylidene)amino]ethyl}benzenesulfonamide
C15H15ClN2O3S
Acta Crystallographica Section E (2008) 64, 4 o725
a=21.069(2)Å b=4.8125(6)Å c=30.838(3)Å
α=90° β=99.942(9)° γ=90°
7-Nitro-5H-thiochromeno[2,3-b]pyridin-5-one
C12H6N2O3S
Acta Crystallographica Section E (2008) 64, 4 o730
a=24.822(2)Å b=3.8884(2)Å c=10.8505(7)Å
α=90.00° β=90.00° γ=90.00°
C21H22N4O3Sn
C21H22N4O3Sn
Acta Crystallographica Section E (2008) 64, 4 m531-m532
a=12.3834(3)Å b=9.9094(2)Å c=17.1730(4)Å
α=90.00° β=103.3020(10)° γ=90.00°
3,3-Dibromo-1-ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C10H9Br2NO3S
Acta Crystallographica Section E (2008) 64, 7 o1270
a=7.7979(5)Å b=11.9645(7)Å c=13.1231(8)Å
α=90.00° β=95.374(3)° γ=90.00°
Potassium 2-iodobenzenesulfonate monohydrate
K,C6H4IO3S,H2O
Acta Crystallographica Section E (2008) 64, 8 m994
a=13.8993(4)Å b=9.0678(3)Å c=8.1654(2)Å
α=90.00° β=92.260(2)° γ=90.00°
N-Chloromethylsaccharin
C8H6ClNO3S
Acta Crystallographica Section E (2007) 63, 10 o4116-o4116
a=9.208(5)Å b=8.643(4)Å c=12.458(6)Å
α=90.00° β=107.46(2)° γ=90.00°
(4<i>R</i>,5<i>R</i>,6<i>S</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,10<i>S</i>,\ 13<i>S</i>)-7,8β-Epoxymomilactone-A
C20H26O4
Acta Crystallographica Section E (2008) 64, 5 o892
a=6.3996(7)Å b=13.1759(3)Å c=20.8540(10)Å
α=90.000° β=90.00° γ=90.00°
N-(4-Chloro-2-nitrophenyl)methanesulfonamide
C7H7ClN2O4S
Acta Crystallographica Section E (2008) 64, 10 o2034-o2035
a=11.728(3)Å b=4.9798(13)Å c=17.988(5)Å
α=90.00° β=107.334(8)° γ=90.00°
<i>N</i>-(4-Chloro-2-nitrophenyl)-<i>N</i>-(methylsulfonyl)acetamide
C9H9ClN2O5S
Acta Crystallographica Section E (2008) 64, 11 o2092
a=9.8071(4)Å b=9.4310(4)Å c=13.5679(7)Å
α=90.00° β=105.883(2)° γ=90.00°
(Cyanomethyl)triphenylphosphonium chloride
C20H17NP,Cl
Acta Crystallographica Section E (2008) 64, 11 o2213
a=11.8269(5)Å b=11.8130(4)Å c=12.8918(5)Å
α=90° β=92.213(2)° γ=90°
Methyl 3-hydroxy-4-oxo-3,4-dihydro-2<i>H</i>-1,2-benzothiazine-3- carboxylate 1,1-dioxide monohydrate
C10H9NO6S,H2O
Acta Crystallographica Section E (2008) 64, 10 o2045
a=7.7504(5)Å b=14.5638(9)Å c=21.0615(14)Å
α=90.00° β=90.00° γ=90.00°
(1<i>E</i>,4<i>E</i>)-1,5-Bis(4-methylphenyl)penta-1,4-dien-3-one
C19H18O
Acta Crystallographica Section E (2008) 64, 8 o1413
a=19.937(2)Å b=5.8637(5)Å c=14.9207(14)Å
α=90.00° β=121.001(3)° γ=90.00°
1-Methyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C9H9NO3S
Acta Crystallographica Section E (2008) 64, 3 o557
a=7.4553(4)Å b=8.5437(4)Å c=8.7097(4)Å
α=67.691(2)° β=70.467(2)° γ=66.327(2)°
(1<i>R</i>,2<i>S</i>,4<i>S</i>,5<i>S</i>)-4-(4-fluorophenyl)- 2-hydroperoxy-4-hydroxy-2-isopropyl-<i>N</i>,5-diphenyl-3,6- dioxabicyclo[3.1.0]hexane-1-carboxamide
C26H24FNO6
Acta Crystallographica Section E (2008) 64, 8 o1548
a=11.7560(6)Å b=11.7489(6)Å c=17.0889(9)Å
α=90.00° β=94.438(2)° γ=90.00°
5<i>H</i>-1-Benzothiopyrano[2,3-<i>b</i>]pyridin-5-one
C12H7NOS
Acta Crystallographica Section E (2008) 64, 9 o1704
a=7.7308(18)Å b=3.8585(9)Å c=15.771(3)Å
α=90.00° β=99.333(9)° γ=90.00°
4 Iodo benzohydrazide
C7H7IN2O
Acta Crystallographica Section E (2008) 64, 11 o2188
a=28.4394(18)Å b=4.4514(3)Å c=13.3216(9)Å
α=90.00° β=94.292(2)° γ=90.00°
2-[N-(2-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=15.734(9)Å b=10.614(6)Å c=7.717(3)Å
α=90.00° β=90.00° γ=90.00°
2-[N-(4-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=7.435(2)Å b=16.006(6)Å c=22.061(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-(benzenesulfonamido)acetate
C9H11NO4S
Acta Crystallographica Section E (2009) 65, 6 o1204
a=9.7268(8)Å b=5.0781(4)Å c=10.9286(9)Å
α=90.00° β=100.087(3)° γ=90.00°
2-(Prop-2-enyl)-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C10H9NO3S
Acta Crystallographica Section E (2009) 65, 6 o1236
a=7.2169(8)Å b=7.8347(7)Å c=10.3849(12)Å
α=105.530(3)° β=91.586(3)° γ=112.047(3)°
4-Benzenesulfonamidobenzoic acid
C13H11NO4S
Acta Crystallographica Section E (2009) 65, 12 o3086
a=5.2050(3)Å b=37.726(2)Å c=7.3781(4)Å
α=90.00° β=117.510(3)° γ=90.00°
2-[(Methylsulfonyl)amino]benzoic acid
C8H9NO4S
Acta Crystallographica Section E (2009) 65, 10 o2453
a=5.2001(2)Å b=8.6120(4)Å c=11.2314(5)Å
α=72.675(3)° β=84.155(3)° γ=86.846(3)°
<i>N</i>-[2-(Aminocarbonyl)phenyl]-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C17H15N3O5S
Acta Crystallographica Section E (2009) 65, 10 o2596
a=8.1377(6)Å b=7.0515(6)Å c=29.069(2)Å
α=90.00° β=96.502(3)° γ=90.00°
(2<i>Z</i>)-2-(4-Methylphenyl)-3-(2-naphthyl)prop-2-enenitrile
C20H15N
Acta Crystallographica Section E (2009) 65, 10 o2409
a=12.3194(11)Å b=16.4796(16)Å c=7.2596(7)Å
α=90° β=90° γ=90°
3-Carbamothioylpyridinium iodide
C6H7N2S,I
Acta Crystallographica Section E (2009) 65, 10 o2423
a=4.4024(3)Å b=8.1943(5)Å c=12.6815(8)Å
α=102.485(2)° β=96.496(2)° γ=102.288(2)°
Bis(1-butyl-3-propylthiourea)dicyanidomercury(II)
C20H40HgN6S2
Acta Crystallographica Section E (2009) 65, 10 m1191-m1192
a=17.4692(3)Å b=9.5928(2)Å c=17.4699(4)Å
α=90° β=111.5400(10)° γ=90°
Piperidinium 4-hydroxy-3-(methoxycarbonyl)-1,2-benzothiazin-2-ide 1,1-dioxide
C5H12N,C10H8NO5S,
Acta Crystallographica Section E (2009) 65, 10 o2451
a=12.0423(5)Å b=9.1791(3)Å c=14.5193(5)Å
α=90.00° β=90.556(2)° γ=90.00°
3,5-Dimethyl-2,6-diphenyl-3,4,5,6-tetrahydro-2<i>H</i>-pyran-4-one
C19H20O2
Acta Crystallographica Section E (2009) 65, 3 o463
a=14.7247(10)Å b=9.2803(7)Å c=23.0393(16)Å
α=90.00° β=90.00° γ=90.00°
1-(5-Hydroxy-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)ethanone
C12H12N2O2
Acta Crystallographica Section E (2009) 65, 2 o330
a=13.8735(7)Å b=9.2037(4)Å c=18.3702(8)Å
α=90.00° β=110.100(2)° γ=90.00°
4-Amino-3-bromobenzoic acid
C7H6BrNO2
Acta Crystallographica Section E (2009) 65, 3 o640
a=24.3968(11)Å b=4.8388(2)Å c=12.8040(5)Å
α=90° β=90° γ=90°
4-Methyl-<i>N</i>-(2-oxo-1-phenylethyl)benzenesulfonamide
C15H15NO4S
Acta Crystallographica Section E (2009) 65, 11 o2797
a=5.6592(12)Å b=11.208(2)Å c=23.342(4)Å
α=90° β=90° γ=90°
Dianilinedibromidozinc(II)
C12H14Br2N2Zn
Acta Crystallographica Section E (2009) 65, 11 m1457
a=25.7545(16)Å b=4.9415(3)Å c=12.1919(8)Å
α=90.000° β=111.035(3)° γ=90.000°
Methyl (4-bromobenzenesulfonamido)acetate
C9H10BrNO4S
Acta Crystallographica Section E (2008) 64, 12 o2380
a=6.0451(2)Å b=7.0369(2)Å c=13.8695(5)Å
α=83.866(2)° β=81.1900(10)° γ=87.027(2)°
2-(Benzenesulfonamido)acetic acid
C8H9NO4S
Acta Crystallographica Section E (2008) 64, 12 o2283-o2284
a=8.5181(3)Å b=11.1302(4)Å c=10.6414(4)Å
α=90.00° β=112.600(2)° γ=90.00°
<i>N</i>-(2,3-Dimethylphenyl)-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine- 3-carboxamide 1,1-dioxide
C18H18N2O4S
Acta Crystallographica Section E (2009) 65, 3 o644-o645
a=10.2461(3)Å b=8.5421(2)Å c=19.8944(5)Å
α=90.00° β=104.8320(10)° γ=90.00°
4-Chloro-1-iodo-2-nitrobenzene
C6H3ClINO2
Acta Crystallographica Section E (2009) 65, 3 o535
a=4.1583(2)Å b=14.5213(7)Å c=13.7990(6)Å
α=90° β=93.361(2)° γ=90°
(2<i>Z</i>)-Methyl 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoate
C7H9N3O3S
Acta Crystallographica Section E (2009) 65, 7 o1455
a=7.8096(4)Å b=8.1994(5)Å c=15.6247(9)Å
α=90° β=92.936(2)° γ=90°
2-(4-Bromobenzenesulfonamido)benzoic acid
C13H10BrNO4S
Acta Crystallographica Section E (2009) 65, 7 o1610-o1611
a=27.8316(11)Å b=8.5684(4)Å c=11.6632(5)Å
α=90° β=98.196(2)° γ=90°
2-(4-Bromobenzenesulfonamido)-2-phenylacetic acid monohydrate
C14H12BrNO4S,H2O
Acta Crystallographica Section E (2009) 65, 8 o1953-o1954
a=5.5654(13)Å b=16.230(4)Å c=17.597(4)Å
α=90° β=90° γ=90°
Poly[hemi-μ-aqua-[μ-2-(2-bromobenzenesulfonamido)benzoato]sodium(I)]
Na,C13H9Br1N1O4S1,0.5(H2O1)
Acta Crystallographica Section E (2009) 65, 8 m982
a=9.1683(6)Å b=9.2722(5)Å c=18.4183(12)Å
α=97.717(2)° β=101.837(2)° γ=101.467(2)°
7-Benzenesulfonamido-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene- 2-carboxylic acid methanol solvate
C15H14N2O5S2,CH4O
Acta Crystallographica Section E (2009) 65, 8 o1737
a=12.0000(2)Å b=6.0964(8)Å c=13.602(2)Å
α=90° β=109.412(7)° γ=90°
4-Hydroxybenzohydrazide
C7H8N2O2
Acta Crystallographica Section E (2009) 65, 8 o1764
a=5.0587(2)Å b=17.2149(9)Å c=7.8178(5)Å
α=90.00° β=93.489(2)° γ=90.00°
<i>S</i>-1,3-Benzothiazol-2-yl (2<i>Z</i>)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanethioate
C13H10N4O2S3
Acta Crystallographica Section E (2009) 65, 8 o1805
a=13.9725(9)Å b=5.0156(3)Å c=21.7664(14)Å
α=90.00° β=90.001(3)° γ=90.00°
{[(4-bromophenyl)sulfonyl]amino}acetic acid
C8H8BrNO4S
Acta Crystallographica Section E (2009) 65, 8 o1816
a=5.0042(4)Å b=7.9997(6)Å c=13.2289(11)Å
α=79.691(4)° β=88.667(5)° γ=81.404(4)°
<i>N</i>'-(4-Bromophenylsulfonyl)isonicotinohydrazide
C12H10BrN3O3S
Acta Crystallographica Section E (2009) 65, 8 o1991
a=10.1229(6)Å b=19.0440(12)Å c=15.0640(7)Å
α=90.00° β=96.862(2)° γ=90.00°
1-Chloromethyl-3-nitrobenzene
C7H6ClNO2
Acta Crystallographica Section E (2010) 66, 3 o608
a=12.1219(10)Å b=4.5104(4)Å c=15.1219(11)Å
α=90° β=112.709(2)° γ=90°
3,3'-(<i>p</i>-Phenylenedimethylene)di-1<i>H</i>-imidazol-1-ium bis(4-nitrobenzoate)--4-nitrobenzoic acid (1/2)
C14H16N42,2(C7H4NO4),2(C7H5NO4)
Acta Crystallographica Section E (2010) 66, 6 o1485
a=7.2659(15)Å b=12.689(3)Å c=13.028(3)Å
α=112.94(3)° β=102.49(3)° γ=101.94(3)°
3-(Piperidin-1-yl)-6-(1<i>H</i>-pyrazol-1-yl)pyridazine
C12H15N5
Acta Crystallographica Section E (2010) 66, 6 o1295
a=5.9665(6)Å b=20.189(3)Å c=9.9695(13)Å
α=90.00° β=103.230(7)° γ=90.00°
2-(4-Acetamidobenzenesulfonamido)-3-methylbutanoic acid
C13H18N2O5S
Acta Crystallographica Section E (2010) 66, 6 o1288
a=5.1649(13)Å b=14.724(5)Å c=20.688(7)Å
α=90° β=90° γ=90°
Hexaaquachromium(III) pyridine-2,4,6-tricarboxylate dihydrate
CrH12O63,C8H2NO63,2(H2O)
Acta Crystallographica Section E (2010) 66, 7 m843
a=7.8610(3)Å b=16.9269(5)Å c=11.6823(4)Å
α=90.00° β=100.6490(10)° γ=90.00°
<i>N</i>-Benzyl-<i>N</i>-ethyl-4-methylbenzenesulfonamide
C16H19NO2S
Acta Crystallographica Section E (2010) 66, 10 o2507
a=8.8144(3)Å b=19.7677(6)Å c=9.8914(4)Å
α=90.00° β=117.6890(10)° γ=90.00°
1-Propyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C11H13NO3S
Acta Crystallographica Section E (2010) 66, 11 o2839
a=7.9448(2)Å b=8.0701(3)Å c=9.6267(2)Å
α=87.468(2)° β=84.097(2)° γ=64.4530(10)°
<i>N</i>-(5-chloro-2-methoxyphenyl)benzenesulfonamide
C13H12ClNO3S
Acta Crystallographica Section E (2010) 66, 11 o2855
a=8.2201(2)Å b=8.9395(2)Å c=10.5544(2)Å
α=77.2060(10)° β=76.3660(10)° γ=66.4080(10)°
2,4,6-Trimethylpyridinium nitrate
C8H12N,NO3
Acta Crystallographica Section E (2010) 66, 9 o2362
a=9.3280(10)Å b=15.1327(13)Å c=6.4967(7)Å
α=90° β=90° γ=90°
Methyl 2-(4-acetamidobenzenesulfonamido)benzoate
C16H16N2O5S
Acta Crystallographica Section E (2011) 67, 4 o903
a=8.2835(2)Å b=9.3722(3)Å c=10.8299(3)Å
α=85.5370(10)° β=88.6140(10)° γ=72.2030(10)°
4-{[(4-Methylphenyl)sulfonyl]amino}benzoic acid
C14H13N1O4S1
Acta Crystallographica Section E (2011) 67, 4 o1018
a=5.1588(2)Å b=6.9277(2)Å c=20.0350(6)Å
α=83.5740(10)° β=86.3570(10)° γ=72.8240(10)°
Lamotriginium dihydrogen phosphate--4-(dimethylamino)benzaldehyde (1/1)
C9H8Cl2N5,H2O4P,C9H11NO
Acta Crystallographica Section E (2010) 66, 10 o2558
a=8.1586(4)Å b=10.5206(6)Å c=13.6359(7)Å
α=98.665(3)° β=98.131(4)° γ=99.746(3)°
(1<i>E</i>)-1-[4-(Dimethylamino)phenyl]pent-1-en-3-one
C13H17NO
Acta Crystallographica Section E (2009) 65, 12 o3063
a=12.6079(14)Å b=15.1331(17)Å c=6.2182(6)Å
α=90.00° β=100.036(5)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-propylbenzenesulfonamide
C15H23NO2S
Acta Crystallographica Section E (2009) 65, 12 o3165
a=8.5532(3)Å b=11.6877(4)Å c=15.4410(5)Å
α=90.00° β=90.649(2)° γ=90.00°
Poly[[di-μ-aqua-(μ-4-formyl-2-methoxyphenolato)disodium] 4-formyl-2-methoxyphenolate]
C8H15Na2O7,C8H7O3
Acta Crystallographica Section E (2010) 66, 2 m149-m150
a=12.2281(6)Å b=6.7681(3)Å c=22.6734(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-{4-[(3,4-Dimethylphenyl)(ethyl)sulfamoyl]phenyl}-<i>N</i>- ethylacetamide
C20H26N2O3S
Acta Crystallographica Section E (2010) 66, 12 o3152
a=8.0882(2)Å b=11.5978(3)Å c=21.2717(5)Å
α=90° β=97.1940(10)° γ=90°
<i>N</i>-(4-Methoxyphenyl)-4-methylbenzenesulfonamide
C14H15NO3S
Acta Crystallographica Section E (2011) 67, 1 o186
a=9.1777(4)Å b=5.2179(2)Å c=15.1621(7)Å
α=90° β=103.518(2)° γ=90°
2-Methyl-5-nitrobenzenesulfonamide
C7H8N2O4S
Acta Crystallographica Section E (2010) 66, 1 o136
a=4.9872(4)Å b=6.2814(5)Å c=28.557(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-[(methylsulfonyl)(propyl)amino]benzoate
C12H17NO4S
Acta Crystallographica Section E (2010) 66, 1 o248
a=10.1762(4)Å b=15.0178(6)Å c=18.0900(8)Å
α=90° β=92.787(2)° γ=90°
<i>N</i>-Phenyl-<i>N</i>-(prop-2-en-1-yl)benzenesulfonamide
C15H15NO2S
Acta Crystallographica Section E (2010) 66, 5 o1087
a=11.6302(8)Å b=5.7041(4)Å c=21.9408(14)Å
α=90.00° β=103.535(4)° γ=90.00°
Methyl 2-ethyl-4-hydroxy-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C12H13NO5S
Acta Crystallographica Section E (2010) 66, 5 o1070
a=7.2460(6)Å b=20.548(2)Å c=8.5710(8)Å
α=90.00° β=90.00° γ=90.00°
[1-(Carboxymethyl)cyclohexyl]methanaminium dihydrogen phosphate
C9H18NO2,H2O4P
Acta Crystallographica Section E (2010) 66, 5 o1074
a=10.473(5)Å b=9.269(3)Å c=26.468(5)Å
α=90° β=90° γ=90°
Piperazine-1,4-diium bis(3,5-dicarboxybenzoate)
C4H12N22,2C9H5O6
Acta Crystallographica Section E (2010) 66, 5 o1097
a=7.3029(15)Å b=8.6758(17)Å c=9.0422(18)Å
α=87.04(3)° β=69.94(3)° γ=83.76(3)°
Dianilinedichloridozinc(II)
C12H14Cl2N2Zn
Acta Crystallographica Section E (2010) 66, 5 m492
a=26.0713(7)Å b=4.79580(10)Å c=11.5880(3)Å
α=90.00° β=108.8230(10)° γ=90.00°
<i>N</i>,<i>N</i>-Dibenzyl-4-methylbenzenesulfonamide
C21H21NO2S
Acta Crystallographica Section E (2010) 66, 5 o1218
a=27.7716(15)Å b=5.9523(3)Å c=22.3140(12)Å
α=90° β=90° γ=90°
<i>N</i>-Ethyl-<i>N</i>-(2-methoxyphenyl)benzenesulfonamide
C15H17NO3S
Acta Crystallographica Section E (2010) 66, 7 o1728
a=9.3098(5)Å b=9.5664(6)Å c=17.1949(10)Å
α=90° β=104.040(2)° γ=90°
Ammonium [(1<i>S</i>)-(<i>endo</i>,<i>anti</i>)]-(-)-3-bromocamphor-8-sulfonate
H4N,C10H14BrO4S
Acta Crystallographica Section E (2010) 66, 7 o1707-o1708
a=7.2449(2)Å b=7.00490(10)Å c=13.2428(3)Å
α=90° β=104.7040(10)° γ=90°
1-Chloromethyl-4-nitrobenzene
C7H6ClNO2
Acta Crystallographica Section E (2010) 66, 7 o1667
a=4.74340(10)Å b=6.4189(2)Å c=24.9413(11)Å
α=90° β=90° γ=90°
<i>N</i>-Cyclohexylbenzamide
C13H17NO
Acta Crystallographica Section E (2010) 66, 7 o1687
a=5.2372(3)Å b=6.5841(4)Å c=16.6029(12)Å
α=90.00° β=91.176(2)° γ=90.00°
<i>N</i>-{[4-(4-Methoxybenzenesulfonamido)phenyl]sulfonyl}acetamide
C15H16N2O6S2
Acta Crystallographica Section E (2010) 66, 7 o1768
a=5.3651(10)Å b=20.551(3)Å c=15.034(2)Å
α=90° β=94.040(7)° γ=90°
<i>N</i>-(2-Methoxyphenyl)benzenesulfonamide
C13H13NO3S
Acta Crystallographica Section E (2010) 66, 7 o1769
a=8.7705(2)Å b=28.1684(7)Å c=10.7256(3)Å
α=90° β=105.9680(10)° γ=90°
<i>N</i>-{4-[(5-Methylisoxazol-3-yl)sulfamoyl]phenyl}benzamide
C17H15N3O4S
Acta Crystallographica Section E (2010) 66, 9 o2264
a=8.2407(6)Å b=23.5069(16)Å c=8.5199(6)Å
α=90° β=92.155(3)° γ=90°
3,3'-Dimethoxy-2,2'-[(4,5-dimethyl-<i>o</i>-phenylene)bis(nitrilomethanylylidene)]diphenol
C24H24N2O4
Acta Crystallographica Section E (2011) 67, 3 o636
a=8.0311(2)Å b=12.5836(3)Å c=20.6174(5)Å
α=86.9000(10)° β=82.5490(10)° γ=81.8060(10)°
4-(2-Methoxybenzylidene)-2-phenyl-1,3-oxazol-5(4<i>H</i>)-one
C17H13NO3
Acta Crystallographica Section E (2009) 65, 4 o842
a=8.8073(6)Å b=9.6140(6)Å c=9.8272(6)Å
α=66.503(4)° β=67.248(4)° γ=71.734(4)°
2-Methoxybenzohydrazide
C8H10N2O2
Acta Crystallographica Section E (2009) 65, 10 o2542
a=7.6486(5)Å b=10.7123(7)Å c=20.4781(13)Å
α=90.00° β=95.563(3)° γ=90.00°
4-Phenylsemicarbazide
C7H9N3O
Acta Crystallographica Section E (2009) 65, 10 o2360
a=16.5984(10)Å b=8.8862(4)Å c=10.3518(6)Å
α=90.00° β=91.359(3)° γ=90.00°
3-Methoxybenzohydrazide
C8H10N2O2
Acta Crystallographica Section E (2009) 65, 10 o2473
a=13.1288(8)Å b=7.5417(4)Å c=17.0734(10)Å
α=90.00° β=92.857(3)° γ=90.00°
Sodium 2-iodobenzenesulfonate monohydrate
Na,C6H4IO3S,H2O
Acta Crystallographica Section E (2008) 64, 12 m1628
a=13.6141(4)Å b=8.8233(3)Å c=7.8493(3)Å
α=90° β=92.1710(10)° γ=90°
6-Bromo-1-ethyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C10H10BrNO3S
Acta Crystallographica Section E (2009) 65, 2 o393
a=7.7164(2)Å b=7.9729(3)Å c=10.4579(3)Å
α=86.767(2)° β=75.7730(10)° γ=66.912(2)°
4-(2-Iodobenzenesulfonamido)benzoic acid monohydrate
C13H10INO4S,H2O
Acta Crystallographica Section E (2009) 65, 2 o230
a=13.8049(9)Å b=8.2756(5)Å c=14.7928(10)Å
α=90° β=117.472(3)° γ=90°
3,3-Dichloro-1-ethyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C10H9Cl2NO3S
Acta Crystallographica Section E (2009) 65, 2 o430
a=7.7416(2)Å b=11.9185(3)Å c=12.9614(3)Å
α=90° β=95.995(2)° γ=90°
2-Chloro-5-(2-iodobenzenesulfonamido)benzoic acid
C13H9ClINO4S
Acta Crystallographica Section E (2009) 65, 2 o281
a=26.6375(9)Å b=8.5532(2)Å c=14.2696(5)Å
α=90° β=111.923(2)° γ=90°
2-Bromo-4-nitroaniline
C6H5BrN2O2
Acta Crystallographica Section E (2009) 65, 3 o480
a=11.098(3)Å b=16.763(4)Å c=3.9540(9)Å
α=90° β=90° γ=90°
2-(2-Iodobenzenesulfonamido)acetic acid
C8H8INO4S
Acta Crystallographica Section E (2009) 65, 3 o549
a=5.5877(2)Å b=8.0145(2)Å c=12.3584(4)Å
α=80.923(2)° β=83.398(2)° γ=88.038(2)°
5-Benzenesulfonamido-2-chlorobenzoic acid
C13H10ClNO4S
Acta Crystallographica Section E (2009) 65, 4 o831
a=11.7139(4)Å b=5.3957(2)Å c=20.7565(8)Å
α=90° β=91.483(2)° γ=90°
Methyl 2-(2-amino-1,3-thiazol-4-yl)-2-[(<i>Z</i>)-methoxycarbonylmethoxyimino]ethanoate
C9H11N3O5S
Acta Crystallographica Section E (2009) 65, 4 o713
a=12.240(2)Å b=5.7500(8)Å c=19.887(3)Å
α=90° β=120.016(8)° γ=90°
2-[(2<i>E</i>)-3-Phenylprop-2-en-1-yl]-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C16H13NO3S
Acta Crystallographica Section E (2009) 65, 5 o1011
a=6.9375(5)Å b=7.1579(4)Å c=29.673(2)Å
α=90.00° β=96.160(4)° γ=90.00°
6-Bromo-1-methyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C9H8BrNO3S
Acta Crystallographica Section E (2009) 65, 5 o1182
a=5.4577(3)Å b=12.6400(8)Å c=15.1258(10)Å
α=90.00° β=96.204(2)° γ=90.00°
(2<i>R</i>)-2-Benzenesulfonamido-2-phenylethanoic acid
C14H13NO4S
Acta Crystallographica Section E (2009) 65, 5 o940
a=5.6022(5)Å b=12.5026(9)Å c=19.7886(15)Å
α=90° β=90° γ=90°